Novel therapies in the treatment of bladder cancer
Dr Petros Grivas and Dr Andrea Necchi
Novel therapies in the treatment of bladder cancer ( Dr Petros Grivas and Dr Andrea Necchi )
3 Jun 2019
Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer wi...
Prof Arnaud Mejean - Paris Descartes University, Paris, France
Update on CARMENA trial: Cytoreductive nephrectomy in metastatic renal cancer with focus on intermediate IMDC-risk population ( Prof Arnaud Mejean - Paris Descartes University, Paris, France )
3 Jun 2019
Enzalutamide as treatment for men with mHSPC who have received testosterone supp...
Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Enzalutamide as treatment for men with mHSPC who have received testosterone suppression ( Dr Christopher Sweeney -  Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2019
Enzalutamide improves survival for men with metastatic hormone-sensitive prostat...
Dr Christopher Sweeney - Dana-Farber Cancer Institute, Boston, USA
Enzalutamide improves survival for men with metastatic hormone-sensitive prostate cancer ( Dr Christopher Sweeney -  Dana-Farber Cancer Institute, Boston, USA )
2 Jun 2019
Comment: Using enzalutamide will allow patients to avoid chemotherapy and steroi...
Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, USA
Comment: Using enzalutamide will allow patients to avoid chemotherapy and steroids improving quality of life ( Dr Neeraj Agarwal - Huntsman Cancer Institute, Salt Lake City, USA )
2 Jun 2019
Treating bladder problems for ovarian cancer patients
Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK
Treating bladder problems for ovarian cancer patients ( Ellie Stewart - Guy’s and St Thomas NHS Foundation Trust, London, UK )
24 May 2019
Filtering through the options: Renal considerations in disease management
Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK
Filtering through the options: Renal considerations in disease management ( Prof Paul Cockwell - University Hospitals Birmingham, Birmingham, UK )
14 May 2019
Controversies in the management of prostate cancer
Prof Mach Roach III - University of California, San Francisco, USA
Controversies in the management of prostate cancer ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019
Local treatment in oligometastatic prostate cancer: Radiotherapy
Prof Mach Roach III - University of California, San Francisco, USA
Local treatment in oligometastatic prostate cancer: Radiotherapy ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019
SBRT photons, protons or carbon for prostate cancer: How good is the data?
Prof Mach Roach III - University of California, San Francisco, USA
SBRT photons, protons or carbon for prostate cancer: How good is the data? ( Prof Mach Roach III - University of California, San Francisco, USA )
9 May 2019
Differences in hormone therapy for patients with advanced metastatic prostate ca...
Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany
Differences in hormone therapy for patients with advanced metastatic prostate cancer ( Prof Axel Merseburger - University Hospital Schleswig-Holstein, Lübeck, Germany )
9 May 2019
State of art in systemic management of nmCRPC
Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France
State of art in systemic management of nmCRPC ( Prof Stéphane Oudard - Georges Pompidou Hospital, Paris, France )
8 May 2019